Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Greinacher, Andreas, Thiele, Thomas, Warkentin, Theodore E., Weisser, Karin, Kyrle, Paul A., Eichinger, Sabine·2021·New England Journal of Medicine
DOI 10.1056/nejmoa2104840

Cited by (1,001)

Items 601–700 of 1,001

  1. Laboratory testing for VITT antibodies
    Theodore Earl Warkentin, Andreas Greinacher · 2022 · Seminars in Hematology
  2. Anti‐severe acute respiratory syndrome coronavirus‐2 adenoviral‐vector vaccines trigger subclinical antiplatelet autoimmunity and increase of soluble platelet activation markers
    Eleonora Petito, Elisabetta Colonna, Emanuela Falcinelli, Anna Maria Mezzasoma, Enrica Cesari, Elisa Giglio, Tiziana Fiordi, Fabio Almerigogna, Alfredo Villa, Paolo Gresele · 2022 · British Journal of Haematology
  3. Retinal vascular occlusion and SARS-CoV-2 vaccination
    Stela Vujosevic, Celeste Limoli, Simona Romano, Lucia Vitale, Edoardo Villani, Paolo Nucci · 2022 · Graefe s Archive for Clinical and Experimental Ophthalmology
  4. Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services
    Karina A. Top, Robert T. Chen, Ofer Levy, Al Ozonoff, Bruce Carleton, Nigel W. Crawford, Clarence Buddy Creech, Sonali Kochhar, Gregory A. Poland, Kimberley Gutu et al. · 2022 · Clinical Infectious Diseases
  5. Thrombotic thrombocytopenia After Sinopharm BBIBP‐CorV COVID‐19 vaccination
    Rezvan Hosseinzadeh, Mohammad Barary, Hamed Mehdinezhad, Terence Tai Weng Sio, Florian Peter Länger, Sahar Khosravi · 2022 · Research and Practice in Thrombosis and Haemostasis
  6. Venous Thromboembolism in Sepsis: From Bench to Bedside
    Eleonora Galli, Elena Maggio, Fulvio Pomero · 2022 · Biomedicines
  7. Cerebral venous thrombosis
    Anisio Adalio de Azevedo Moraes, Adriana Bastos Conforto · 2022 · Arquivos de Neuro-Psiquiatria
  8. COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
    Luca M. Zaeck, Corine H. GeurtsvanKessel, Rory D. de Vries · 2023 · The Lancet Respiratory Medicine
  9. Sex-Differential and Non-specific Effects of Vaccines Over the Life Course
    Laura A. St Clair, Sabal Chaulagain, Sabra L. Klein, Christine Stabell Benn, Katie L. Flanagan · 2023 · Current topics in microbiology and immunology
  10. Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis
    Jae Chan Chang, H. Bradford Hawley · 2021 · Medicina
  11. Successful treatment of acute spleno-porto-mesenteric vein thrombosis after ChAdOx1 nCoV-19 vaccine: a case report
    Umbrello, Michele, Brena, Nicola, Vercelli, Ruggero, Foa, Riccardo Alessandro, Femia, Marco, Rossi, Umberto, Podda, Gian Marco, Cortellaro, Francesca, Muttini, Stefano · 2021 · Journal of Critical Care
  12. Imaging of Oxford/AstraZeneca® COVID-19 vaccine-induced immune thrombotic thrombocytopenia
    Garnier, Matthieu, Curado, Adelya, Billoir, Paul, Barbay, Virginie, Demeyere, Matthieu, Dacher, Jean-Nicolas · 2021 · Diagnostic and Interventional Imaging
  13. What Lessons can Be Learned From the Management of the COVID-19 Pandemic?
    Gerry A. Quinn, Ronan Connolly, Coilín Oscar ÓhAiseadha, Paul Dylan Hynds, Philipp Bagus, Ronald B. Brown, Carlos F. Cáceres, C. E. H. Craig, Michael Connolly, José L. Domingo et al. · 2025 · International Journal of Public Health
  14. Therapeutic plasma exchange (TPE) as a plausible rescue therapy in severe vaccine-induced immune thrombotic thrombocytopenia
    Gail Rock, Viktoria Weber, Bernd Georg Stegmayr · 2021 · Transfusion and Apheresis Science
  15. Anti‐PF4 testing for vaccine‐induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021
    Christopher Reilly‐Stitt, Steve Kitchen, Ian Jennings, Kevin Horner, Robert L. Jones, Mike Makris, Isobel D. Walker · 2021 · Journal of Thrombosis and Haemostasis
  16. Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine
    Marie‐Estelle Gaignard, Sven Lieberherr, Andreas Wolfgang Schoenenberger, Rudolf A. Benz · 2021 · HemaSphere
  17. To clot or not to clot? Ad is the question—Insights on mechanisms related to vaccine‐induced thrombotic thrombocytopenia
    Maha Othman, Alexander T. Baker, Гупало Елена Михайловна, Abdelrahman Elsebaie, Carly M. Bliss, Matthew Thomas Rondina, David Lillicrap, Alan L. Parker · 2021 · Journal of Thrombosis and Haemostasis
  18. Side effects following COVID-19 vaccination: A cross-sectional survey with age-related outcomes in Saudi Arabia
    Ahlam Alghamdi, Alnada Abdalla Mohamed Ibrahim, Mohammed A. Alraey, Afrah Alkazemi, Isra Alghamdi, Ghada Alwarafi · 2021 · Journal Of Advanced Pharmacy Education And Research
  19. Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26)
    Jack R. Hemsath, A. Manuel Liaci, Jeffrey D. Rubin, Brian J. Parrett, Shao‐Chia Lu, Tien Anh Nguyen, Mallory A. Turner, Christopher Y. Chen, Karolina Cupelli, Vijay S. Reddy et al. · 2021 · Journal of Virology
  20. Protective Effect of Melatonin Administration against SARS-CoV-2 Infection: A Systematic Review
    Antonio Molina‐Carballo, Rafael Palacios-López, Antonio Emilio Jerez-Calero, María del Carmen Augustin-Morales, Ahmad Agil, Antonio Muñoz‐Hoyos, Antonio Muñoz-Gallego · 2021 · Current Issues in Molecular Biology
  21. Differential Effects of Platelet Factor 4 (CXCL4) and Its Non-Allelic Variant (CXCL4L1) on Cultured Human Vascular Smooth Muscle Cells
    Dawid Kaczor, Rafael Kramann, Tilman M. Hackeng, Leon J. Schurgers, Rory R. Koenen · 2022 · International Journal of Molecular Sciences
  22. Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of Publicity
    Robin Esmond Ferner, Richard Stevens, Christopher Anton, Jeffrey K Aronson · 2022 · Drug Safety
  23. Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects
    Yuri A. Lazebnik · 2021 · Oncotarget
  24. Vision-Threatening Ocular Adverse Events after Vaccination against Coronavirus Disease 2019
    Mihyun Choi, Min-Hwan Seo, Kwang-Eon Choi, Sukyeon Lee, Boyoon Choi, Cheolmin Yun, Seong‐Woo Kim, Yong Yeon Kim · 2022 · Journal of Clinical Medicine
  25. Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil
    Patrícia Mouta Nunes de Oliveira, Daniela Palheiro Mendes-de-Almeida, Victor Bertollo Gomes Pôrto, Catherine Crespo Cordeiro, Gabriellen Vitiello Teixeira, Renata Saraiva Pedro, Paulo Roberto Gomes Takey, Letícia Kegele Lignani, Janaína Reis Xavier, Vitor Cardoso Doria da Gama et al. · 2022 · Vaccine
  26. Modelling herd immunity requirements in Queensland: impact of vaccination effectiveness, hesitancy and variants of SARS-CoV-2
    Paula Sanz‐Leon, Lachlan H. W. Hamilton, Sebastian J. Raison, Anna J. X. Pan, Nathan J. Stevenson, Robyn M. Stuart, Romesh Abeysuriya, Cliff C. Kerr, Stephen Bernard Lambert, James A. Roberts · 2022 · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences
  27. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase
    Anita A. G. A. van de Munckhof, Erik Lindgren, Timothy John Kleinig, Thalia Shoshana Field, Charlotte Cordonnier, Katarzyna Krzywicka, Sven Poli, Mayte Sánchez van Kammen, Afshin Borhani‐Haghighi, Robin Lemmens et al. · 2022 · Stroke
  28. COVID-19 Vaccines against Omicron Variant: Real-World Data on Effectiveness
    Yousra Kherabi, Odile Launay, Liêm Binh Luong Nguyen · 2022 · Viruses
  29. From the Discovery of ADAMTS13 to Current Understanding of Its Role in Health and Disease
    Adriana Inés Woods, Juvenal Paiva, Celia Dos Santos, María Fabiana Alberto, Analía Sánchez‐Luceros · 2022 · Seminars in Thrombosis and Hemostasis
  30. Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain
    Edward Burn, Elena Roel, Andrea Pistillo, Sergio Fernández‐Bertolín, María Aragón, Berta Raventós, Carlen Reyes, Katia M.C. Verhamme, Peter R. Rijnbeek, Xintong Li et al. · 2022 · Nature Communications
  31. Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?
    Altijana Hromić‐Jahjefendić, Debmalya Barh, Vladimir Nikolaevich Uversky, Alaa A. A. Aljabali, Murtaza M. Tambuwala, Khalid Jamaan Alzahrani, Fuad M. Alzahrani, Saleh Alshammeri, Kenneth H. Lundstrom · 2023 · Vaccines
  32. A Case of Idiopathic Thrombocytopenic Purpura After Booster Dose of BNT162b2 (Pfizer-Biontech) COVID-19 Vaccine
    Srikrishna Varun Malayala, Bhavani Nagendra Papudesi, Rishika Sharma, Urwat Til Vusqa, Ambreen Raza · 2021 · Cureus
  33. SARS-CoV-2 vaccine-induced cerebral venous thrombosis
    Alfonso Ciccone · 2021 · European Journal of Internal Medicine
  34. Vaccine‐induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism
    Mouhamed Yazan Abou‐Ismail, Karen A. Moser, Kristi Johnson Smock, Ming Yeong Lim · 2021 · American Journal of Hematology
  35. Early approval of COVID-19 vaccines: Pros and cons
    Md Arifur Rahman, Md Sayeedul Islam · 2021 · Human Vaccines & Immunotherapeutics
  36. European stroke organization interim expert opinion on cerebral venous thrombosis occurring after SARS-CoV-2 vaccination
    José Manuel Ferro, Diana Aguiar de Sousa, Jonathan M. Coutinho, Ida Martinelli · 2021 · European Stroke Journal
  37. Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study
    Hwanhee Park, Ki Wook Yun, Kyung-Ran Kim, Seung Ha Song, Bin Ahn, Doo Ri Kim, Gi Beom Kim, June Huh, Eun Hwa Choi, Yae‐Jean Kim · 2021 · Journal of Korean Medical Science
  38. Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters
    Rakesh Kulkarni, Wen-Ching Chen, Ying Lee, Chi‐Fei Kao, Shiu-Lok Hu, Hsiu‐Hua Ma, Jia‐Tsrong Jan, Chun‐Che Liao, Jian‐Jong Liang, Hui‐Ying Ko et al. · 2021 · PLoS ONE
  39. Long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia
    J. Thaler, Petra Jilma‐Stohlawetz, Nazanin Samadi, Florian Roitner, Eva Mikušková, Stephan Kudrnovsky‐Moser, Joachim Rettl, Raphael Preiss, Peter Quehenberger, Ingrid Pabinger et al. · 2021 · Thrombosis Research
  40. SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies
    Ali Salimi Jeda, Sina Abbassi, Atieh Mousavizadeh, Maryam Esghaie, Farah Bokharaei‐Salim, Farhad Jeddi, Maryam Shafaati, Asghar Abdoli · 2021 · International Immunopharmacology
  41. COVID-19, gender and estroprogestins, what do we know?
    Tiziana Fidecicchi, Franca Fruzzetti, Iñaki Lete, Joaquím Calaf · 2021 · The European Journal of Contraception & Reproductive Health Care
  42. Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection
    Catherine Chen, Aisah R Amelia, George W. Ashdown, Ivo Müeller, Anna K. Coussens, Emily Marie Eriksson · 2021 · Molecular Medicine
  43. Stroke Among SARS-CoV-2 Vaccine Recipients in Mexico
    Diego López-Mena, Miguel García-Grimshaw, Sergio Saldivar-Dávila, Laura Elena Hernandez-Vanegas, María del Mar Saniger-Alba, Alonso Gutiérrez, Roger Carrillo-Mezo, Hector Eduardo Valdez-Ruvalcaba, Vanessa Cano-Nigenda, Fernando Daniel Flores-Silva et al. · 2022 · Neurology
  44. Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 Vaccination
    Emilia Cirillo, Ciro Esposito, Giuliana Giardino, Gaetano Azan, Simona Fecarotta, Stefania Pittaluga, Lucia Ruggiero, Ferdinando Barretta, Giulia Frisso, Luigi Daniele Notarangelo et al. · 2022 · Frontiers in Immunology
  45. Cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia after a second ChAdOx1 nCoV-19 dose
    Katarzyna Krzywicka, Anita A. G. A. van de Munckhof, Julian Zimmermann, Felix Jürgen Bode, Giovanni Frisullo, Theodoros Karapanayiotides, Bernd Pötzsch, Mayte Sánchez van Kammen, Mirjam R. Heldner, Marcel Arnold et al. · 2022 · Blood
  46. Immune-mediated adverse events post-COVID vaccination and types of vaccines: a systematic review and meta-analysis
    Hind A. ELsawi, Ahmed El-Borollosy · 2022 · The Egyptian Journal of Internal Medicine
  47. New-Onset Acute Kidney Disease Post COVID-19 Vaccination
    Yebei Li, Meiying Rao, Gaosi Xu · 2022 · Vaccines
  48. Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
    Marie Alexandre, Romain Marlin, Mélanie Prague, Séverin Coléon, Nidhal Kahlaoui, Sylvain Cardinaud, Thibaut Naninck, Benoît Delache, Mathieu Surénaud, Mathilde Galhaut et al. · 2022 · eLife
  49. Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy
    Pavlina Spiliopoulou, Helena J. Janse van Rensburg, Lisa M. Avery, Vathany Kulasingam, Albiruni Ryan Abdul Razak, Philippe Lucien Bedard, Aaron Richard Hansen, Andrzej J. Chruscinski, Ben Wang, Maria Kulikova et al. · 2023 · Cell Death and Disease
  50. The top 100 most cited articles on COVID-19 vaccine: a bibliometric analysis
    Weigang Wang, Hu Wang, Tian Yao, Yandi Li, Linzhu Yi, Ying Gao, Jia Lian, Yongliang Feng, Suping Wang · 2023 · Clinical and Experimental Medicine
  51. Cartilage-targeting mRNA-lipid nanoparticles rescue perifocal apoptotic chondrocytes for integrative cartilage repair
    Xinning Yu, Tengjing Xu, Huimin Shi, Jianqiao Hong, Xiaoqiang Jin, Le Cao, Jiajie Wang, Yunting Lin, Zongyou Pan, Siheng Wang et al. · 2023 · Chemical Engineering Journal
  52. Vaccine-induced immune thrombotic thrombocytopenia: what do we know hitherto?
    Renat Roytenberg, Adolfo García‐Sastre, Wei Li · 2023 · Frontiers in Medicine
  53. COVID-19
    Kristen Marks, Roy M. Gulick · 2023 · Annals of Internal Medicine
  54. "When," "Where," and "How" of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review
    Nicholas George Kounis, Christos Gogos, Cesare DE GREGORIO, Ming‐Yow Hung, Sophia A. Kouni, Efthymios P. Tsounis, Stelios F. Assimakopoulos, Soheila Pourmasumi, Virginia Mplani, George Servos et al. · 2024 · Balkan Medical Journal
  55. Vaccine-induced immune thrombotic thrombocytopenia: current evidence, potential mechanisms, clinical implications, and future directions
    Benjamin Marchandot, Anaïs Curtiaud, Antonin Trimaille, Laurent Sattler, L. Grunebaum, Olivier Morel · 2021 · European Heart Journal Open
  56. Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome
    Julie Carré, Georges Jourdi, Nicolas Gendron, Dominique Helley, Pascale Gaussem, Luc Darnige · 2021 · International Journal of Molecular Sciences
  57. Meta-Analysis of Risk of Vaccine-Induced Immune Thrombotic Thrombocytopenia Following ChAdOx1-S Recombinant Vaccine
    Benjamin T.B. Chan, Pavlos Bobos, Ayodele Odutayo, Menaka Pai · 2021 · medRxiv
  58. Thrombotic thrombocytopenia due to SARS-CoV-2 vaccination
    Keith R. McCrae · 2021 · Cleveland Clinic Journal of Medicine
  59. Using Nonheparin Anticoagulant to Treat a Near-Fatal Case With Multiple Venous Thrombotic Lesions During ChAdOx1 nCoV-19 Vaccination-Related Vaccine-Induced Immune Thrombotic Thrombocytopenia
    Samuel Bersinger, Kevin Lagarde, Raphaël Marlu, Gilles Pernod, Jean‐François Payen · 2021 · Critical Care Medicine
  60. Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine
    Kyungmin Huh, Yewon Na, Young‐Eun Kim, Munkhzul Radnaabaatar, Kyong Ran Peck, Jaehun Jung · 2021 · Journal of Korean Medical Science
  61. A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
    Marvin J. Sklar, Santina E. Maiolatesi, Noelle B. Patterson, Martha Sedegah, Keith J. Limbach, Nimfa C. Teneza-Mora, Ilin Chuang, Monique Hollis-Perry, Jo Glenna Banania, Ivelese Guzman et al. · 2021 · PLoS ONE
  62. Rare case of COVID-19 vaccine-associated intracranial haemorrhage with venous sinus thrombosis
    Pujon Purkayastha, Charlie Mckechnie, Pallavi Kalkur, Marie Scully · 2021 · BMJ Case Reports
  63. Observations on improving COVID-19 vaccination responses in kidney transplant recipients: heterologous vaccination and immunosuppression modulation
    Christophe Masset, Simon Ville, Claire Garandeau, Florent Leborgne, Thibaut Letellier, Diego Cantarovich, Aurélie Meurette, Cécile Guillot-Gueguen, Maxime Bentoumi-Loaec, Magali Giral et al. · 2021 · Kidney International
  64. Acute liver failure after vaccination against of COVID-19; a case report and review literature
    Masoudreza Sohrabi, Elham Sobhrakhshankhah, Hosein Ziaei, Manizhe Ataee Kachuee, Farhad Zamani · 2021 · Respiratory Medicine Case Reports
  65. Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study
    Prativa Subedi, Gopal Kumar Yadav, Binod Paudel, Anu Regmi, Prajjwal Pyakurel · 2021 · PLoS ONE
  66. MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19
    Anna Francis, Jacqueline A. Palace, Lars H. Fugger · 2022 · The Lancet Neurology
  67. Homologous and Heterologous Anti-COVID-19 Vaccination Does Not Induce New-Onset Formation of Autoantibodies Typically Accompanying Lupus Erythematodes, Rheumatoid Arthritis, Celiac Disease and Antiphospholipid Syndrome
    Christoph Thurm, Annegret Reinhold, Katrin Borucki, Sascha Kahlfuß, Eugen Feist, Jens Schreiber, Dirk Reinhold, Burkhart L. Schraven · 2022 · Vaccines
  68. Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review
    Talal Almas, Sarah Rehman, Eyad Z. Mansour, Tarek Khedro, Ali Alansari, Jahanzeb Malik, Norah Alshareef, Vikneswaran Raj Nagarajan, Abdulla Hussain Al-Awaid, Reema Alsufyani et al. · 2022 · Biomedicine & Pharmacotherapy
  69. SARS-CoV-2 Vaccination and the Bridge between First and Fourth Dose: Where Are We?
    Cristina Stasi, Barbara Meoni, Fabio Voller, Caterina Silvestri · 2022 · Vaccines
  70. Keeping up with the COVID's—Could siRNA‐based antivirals be a part of the answer?
    Helen Forgham, Aleksandr Käkinen, Ruirui Qiao, Thomas Paul Davis · 2022 · Exploration
  71. Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?
    Yiran E. Li, Shuyi Wang, Russel Joseph Reiter, Jun Tao Ren · 2022 · International Journal of Infectious Diseases
  72. Do we miss rare adverse events induced by COVID-19 vaccination?
    Zeinab Mohseni Afshar, Ali Tavakoli Pirzaman, Jackson Jeikai Liang, Akanksha Sharma, Marzieh Pirzadeh, Arefeh Babazadeh, Erfan Hashemi, Niloofar Deravi, Sadaf Abdi, Amirreza Allahgholipour et al. · 2022 · Frontiers in Medicine
  73. Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination
    Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, Robyn E. O’Hehir, Menno C. van Zelm · 2022 · Biochemical Society Transactions
  74. COVID-19 vaccination and Atypical hemolytic uremic syndrome
    Romy N. Bouwmeester, Esther M.G. Bormans, Caroline Duineveld, Arjan D. van Zuilen, Anne-Els van de Logt, Jack F.M. Wetzels, Nicole C. A. J. van de Kar · 2022 · Frontiers in Immunology
  75. Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®
    Sevastyan O. Rabdano, Ellina Ruzanova, Iuliia V. Pletyukhina, Nikita Sergeevich Saveliev, Kirill Leonidovich Kryshen, A.E. Katelnikova, Petr P. Beltyukov, Liliya N. Fakhretdinova, Ariana Safi, German O. Rudakov et al. · 2023 · Vaccines
  76. Thrombocytopenia after COVID-19 vaccination
    Kristian Hay Kragholm, Maurizio Sessa, Thomas Mulvad, Mikkel Porsborg Andersen, Helle Collatz Christensen, Stig Nikolaj Fasmer Blomberg, Freddy Knudsen Lippert, Søren Søndergaard Mikkelsen, Peter Derek Christian Leutscher, Dorte Melgaard et al. · 2021 · Journal of Autoimmunity
  77. Controversies and Challenges of Mass Vaccination against SARS-CoV-2 in Italy: Medico-Legal Perspectives and Considerations
    Rosario Barranco, Gabriele Rocca, Andrea Molinelli, Francesco Ventura · 2021 · Healthcare
  78. SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia
    Jacob Appelbaum, Donald M. Arnold, John G. Kelton, Terry Gernsheimer, Stefan D. Jevtic, Nikola Ivetic, James W. Smith, Ishac Nazy · 2021 · Blood Advances
  79. Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study
    Elena Campello, Cristiana Bulato, Chiara Simion, Luca Spiezia, Claudia Maria Radu, Sabrina Gavasso, Francesca Sartorello, Graziella Saggiorato, Patrizia Zerbinati, Mariangela Fadin et al. · 2022 · Thrombosis and Haemostasis
  80. DNA Nanotechnology‐Engineered Supramolecular Hydrogel Biosensor for Cancer Diagnosis via Extracellular Vesicles
    Jianpu Tang, Zhen Duo Cui, Qian Li, Bin Ke, Peifeng Liu, Dayong Yang, Chi Yao · 2025 · Advanced Functional Materials
  81. Coronavirus disease 2019 vaccination in transplant recipients
    Christiane Sigrid Eberhardt, Elisa Balletto, Markus Cornberg, Małgorzata Mikulska · 2021 · Current Opinion in Infectious Diseases
  82. Cutaneous thrombosis associated with skin necrosis following Oxford‐AstraZeneca COVID‐19 vaccination
    Ravi Ramessur, Nawar Saffar, Branislav Czako, Ashish Chandra Agarwal, Kapila Batta · 2021 · Clinical and Experimental Dermatology
  83. Targeting SARS-CoV-2-Platelet Interactions in COVID-19 and Vaccine-Related Thrombosis
    Dermot Cox · 2021 · Frontiers in Pharmacology
  84. Update on Coronavirus 2019 Vaccine Guidelines for Transplant Recipients
    Vivek Balkrishna Kute, Hari Shankar Meshram, Ashish Sharma, Arpita Ray Chaudhury, S Sudhindran, Alla Gopala Krishna Gokhale, Milind Padmakar Hote, Randeep Guleria, Devinder Singh Rana, Jai Prakash et al. · 2021 · Transplantation Proceedings
  85. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
    Gyungah Kim, Eun‐Ji Choi, Han‐Seung Park, Jung‐Hee Lee, Je‐Hwan Lee, Kyoo‐Hyung Lee · 2021 · Journal of Korean Medical Science
  86. Atypical Hemolytic Uremic Syndrome after ChAdOx1 nCoV-19 Vaccination in a Patient with Homozygous CFHR3/CFHR1 Gene Deletion
    Francisco Alexandre Dina Ferrer, Marisa Roldão, Cátia Raquel Figueiredo, Karina Lopes · 2021 · The Nephron journals/Nephron journals
  87. Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA COVID‐19 vaccine
    Davide Flego, Simone Cesaroni, Giulio Francesco Romiti, Bernadette Corica, Ramona Marrapodi, Noemi Scafa, Francesca Maiorca, Ludovica Lombardi, Davide Pallucci, Fabio Maria Pulcinelli et al. · 2022 · Journal of Thrombosis and Haemostasis
  88. Cerebral venous sinus thrombosis after adenovirus-vectored COVID-19 vaccination: review of the neurological-neuroradiological procedure
    Matthias Wittstock, Uwe Walter, Erik Volmer, Alexander Storch, Marc‐André Weber, Annette Großmann · 2022 · Neuroradiology
  89. Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine
    Helen J. Mayfield, Colleen L. Lau, Jane E. Sinclair, Samuel J. Brown, Andrew Baird, John C. B. Litt, Aapeli Vuorinen, Kirsty Renfree Short, Michael Waller, Kerrie Lee Mengersen · 2022 · Vaccine
  90. Association of Cerebral Venous Thrombosis with mRNA COVID-19 Vaccines: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database
    Jin Kee Park, Moo‐Seok Park, Hyung Jun Kim, Tae‐Jin Song · 2022 · Vaccines
  91. Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
    María Orietta Borghi, Mauro Bombaci, Caterina Bodio, Paola Adele Lonati, Andrea Gobbini, Mariangela Lorenzo, Erminio Torresani, A. Dubini, Ilaria Bulgarelli, Francesca Solari et al. · 2022 · Frontiers in Immunology
  92. COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disorders
    Alessia Cozzolino, Valeria Hasenmajer, John D C Newell-Price, Andrea Maria Isidori · 2023 · Endocrine
  93. Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia
    Angela Huynh, Donald M. Arnold, Nikola Ivetic, Rumi Clare, Milena Hadzi‐Tosev, Yang Liu, James W. Smith, Anna-Lise Bissola, Mercy Daka, John G. Kelton et al. · 2023 · Journal of Thrombosis and Haemostasis
  94. Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis
    Alvina Widhani, Anshari Saifuddin Hasibuan, Retia Rismawati, Suzy Maria, Sukamto Koesnoe, Muhammad Ikrar Hermanadi, Youdiil Ophinni, Chika Yamada, Kuntjoro Harimurti, Aldean Nadhyia Laela Sari et al. · 2023 · Vaccines
  95. Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics
    Kirk D. Haltaufderhyde, Brian Roberts, Sundos Khan, Frances E. Terry, Christine Boyle, Mitchell McAllister, William D Martin, Amy S. Rosenberg, Anne Searls De Groot · 2023 · The AAPS Journal
  96. Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT
    Jing Jing Wang, Marijn van der Neut Kolfschoten, Lucy Rutten, Bridie Armour, Chee Wee Tan, Tim Chataway, Rinke Bos, Annemart Koornneef, Pravien D. Abeywickrema, Rick Kapur et al. · 2023 · Blood
  97. Immunologic Effects of Heparin Associated With Hemodialysis: Focus on Heparin-Induced Thrombocytopenia
    Theodore Earl Warkentin · 2023 · Seminars in Nephrology
  98. Vaccine-Induced Immune Thrombotic Thrombocytopenia: Clinicopathologic Features and New Perspectives on Anti-PF4 Antibody-Mediated Disorders
    Yi Zhang, Anna-Lise Bissola, Jared Treverton, Michael Hack, Mark Lychacz, Sarah Kwok, Addi Arnold, Ishac Nazy · 2024 · Journal of Clinical Medicine
  99. Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding
    Gemma E. Hartley, Holly A. Fryer, Paul A. Gill, Irene Boo, Scott J. Bornheimer, Philip Mark Hogarth, Heidi E. Drummer, Robyn E. O’Hehir, Emily S.J. Edwards, Menno C. van Zelm · 2024 · npj Vaccines
  100. Rapid Detection and Inhibition of SARS‐CoV‐2‐Spike Mutation‐Mediated Microthrombosis
    Sandro Satta, Angela C. Lai, Susana Cavallero, Cayden Williamson, Justin Chen, Ana M. Blázquez‐Medela, Mehrdad Roustaei, Barbara Jane Dillon, Nureddin A. Ashammakhi, Dino Di Carlo et al. · 2021 · Advanced Science